About us
Home > About Us > Company Profile

Company Profile


Athena Lab Technology Co., Ltd. is a bio-tech company that specializes in the research, development, manufacture and distribution of the medical diagnostic products. Our high quality and competitively priced rapid diagnostic tests have extensive application in clinics, hospitals, epidemic prevention stations and customs. With strong support from the government and local university, Athena has obtained ISO9001 and ISO13485 certificate. We also got GMP, FDA and CE certification.

Now Athena is capable of producing high-quality fertility test, infectious diseases test, Tumor Marker test, sexually transmitted diseases test and drug test, almost 100 diagnostic reagents. We offer our rapid diagnostic test products in the form of finished products as well as semi-finished products. We promote our brand ATHENA all over the world, and OEM cooperation is also available to help you create your own brand. By far, our company has already established reliable business relationships with about 50 countries.

Our mission is "To develop and produce the highest quality of rapid test products and provide exceptional service and technical support to every customer". We do believe our best products, competitive price and good service verily make you satisfied.

Product Range Focus
ATHENA lab currently sells over 100 diagnostic products that aid in the detection of pregnancy (hCG), ovulation (LH), menopause (FSH), HBsAg, HBsAb, HBeAg, HBeAb, HBcAb, HCV, HIV, H. Pylori, malaria, strep A, chlamydia, syphilis, mono, dengue, gonorrhea, tuberculosis, rotavirus, adenovirus, ToRCH, FOB, PSA, AFP, CEA, troponin I, myoglobin, CRP and drugs of abuse. We mainly export our products to Asia, the Middle East, Africa, Russia and Latin America. Throughout the world, we have introduced our new urinalysis reagent strips and urine analyzers, EIA/ELISA, and blood glucose monitoring systems, making high quality and affordable testing products available for more people worldwide. We have a number of new products in the pipeline for introduction this year.